...Loading

Loading...

Register Login

About us Toggle Dropdown
News
Our resources Toggle Dropdown
Learning Toggle Dropdown
Community resources Toggle Dropdown
Help Toggle Dropdown

Home
Our resources
Webkits
Medicines safety

Medicines safety

Webkit
Medicines safety

Here are all our resources related to medicines safety. If you have something that you would like to share with the community, please get in touch.

B260: Acute Kidney Injury (AKI) - Sick day guidance

This bulletin provides information on offering individualised sick day guidance to patients when they are well, so that they are able to proactively manage medication known to impair renal function during illness or fever and reduce the risk of AKI.

B248: Amiodarone and Dronedarone

This resource supports the implementation of the NHS England items which should not routinely be prescribed in primary care guidance.

B253. Anticholinergic burden

This bulletin discusses the review of treatment with anticholinergic drugs and the different scales available to support review. Support materials are available to identify the risk in patients and support appropriate action to reduce anticholinergic burden.

348: Antiepileptic drugs

This bulletin includes new valproate safety information and support to appropriately switch antiepileptic drugs to safer or less costly alternatives.

B194: Co-proxamol

This bulletin discusses the use of co-proxamol and supports reviewing and discontinuing prescribing in patients still taking this unlicensed medicine.

B353. Dependence forming medicines

This bulletin provides support for prescribing of and managing withdrawal from dependence forming medicines including opioids, benzodiazepines, gabapentinoids, Z-drugs and antidepressants in primary care.

B228: Emollients, paraffin content and fire risk

This bulletin aims to highlight the fire risk associated with emollient products and measures which need to be taken to reduce this risk.

B285: Fentanyl

This updated resource supports the review of the prescribing of immediate-release fentanyl in line with national guidance. Deprescribing and switching options are considered.

B281: Implementing NICE guidance in CKD and AKI

Part 1 of this two part bulletin covers the assessment and management of chronic kidney disease (CKD) in line with NICE NG203 and drugs which are likely to cause kidney damage.

Part 2 covers the current advice prevention, detection and management of acute kidney injury (AKI) in line with NICE NG148.

B352: Insomnia

This bulletin contains recommendations to optimise prescribing in insomnia.

B361: Medicines without harm

These resources support the implementation of local campaigns for the World Health Organisation (WHO) global patient safety challenge, medication without harm.

B318: Melatonin

This bulletin focuses on melatonin and provides information on ensuring that prescribing is appropriate, reviewing ongoing prescribing and deprescribing melatonin.

B250: Modafinil (Archived)

This bulletin and supporting materials review the place in therapy for modafinil in light of the MHRA restrictions on prescribing indications due to safety concerns.

B265: NSAIDs

These resources look at the safety implications of long term treatment with NSAIDs and support treatment initiation and review.

B267: PPIs - Long term safety and gastroprotection

This bulletin and implementation resources focus on reducing PPI prescribing for safety reasons by reviewing the continued need and stepping down or deprescribing where appropriate in line with current guidance.

B288: Medicines safety

This bulletin offers guidance and background information on medicines safety. This includes the role of the Medicines Safety Officer (MSO) and the Medical Devices Safety Officer (MDSO).

B361: Medicines without harm

These resources support the implementation of local campaigns for the World Health Organisation (WHO) global patient safety challenge, medication without harm.

Bulletin 361: Medicines without harm >

Developing pragmatic, evidence based strategies to help people safely and calmly taper off and stop antidepressant therapy

GRASP suite introduction and GRASP AF

The PRIMIS team from Nottingham University showcase GRASP suite introduction and GRASP AF.

GRASP COPD

The PRIMIS team from Nottingham University showcased GRASP COPD.

GRASP Heart failure

The PRIMIS team from Nottingham University showcased GRASP heart failure.

Me & My Medicines - Overcoming the medicines challenges

Graham Prestwich, Public and Patient Engagement Lead from Yorkshire & Humber AHSN, who explored from a patient and carer perspective ways the collaboration which can be improved and how better outcomes can and will become much more likely.

Safe and appropriate medicines use

This webinar discussed the rationale and evidence behind the Safe and Appropriate Medicine Use document, as well as the importance of this work and its practical implementation within the care home setting.

Patient centred approaches to medicines adherence

Nina Barnett, from the NHS Specialist Pharmacy Service Medicines Use and Safety team presented their work on patient centred approaches to medicines adherence.

PINCER - A proven pharmacist-led IT-based intervention to reduce clinically important medication errors in primary care

PINCER is a proven pharmacist-led IT-based intervention to reduce clinically important medication errors in primary care.

Clozapine induced constipation - implementing the MHRA alert

Vasileios Voulgaropoulos, Principal Clinical Pharmacist, Hertfordshire Partnership University NHS Foundation Trust, presented a "bite-sized" reminder of the potentially fatal risks of clozapine induced constipation. The webinar also covered warnings and advice given by the MHRA to healthcare professionals in both primary and secondary care.

Scorecards

The scorecards on our data hub are available at both organisation (commissioner) and practice level

Gold award winner (2021) - ACB Triage and Review for Medicines Optimisation in Care Homes and Beyond.. - East Lancashire CCG and Hospital Trust

East Lancashire Specialist Medicines Optimisation in Care Home Team (SMOCH) led an initiative to triage all frail older people for Anticholinergic Burden (ACB) and review medicines if the patient had an ACB score of 3+.

Winner - Patient safety (2021) - East Lancashire CCG

This webinar covered the Whole System Improvement in Opioid Safety using Opioid Reduction Pathway. East Lancashire CCG covers one of the most deprived counties in the country with high rates of opioid prescriptions for non-cancer pain (oxycodone and fentanyl). The CCG, NHS East Lancashire Chronic Pain Team along with the Local Authority and Substance Misuse Service took a collaborative approach to design new pathways for chronic pain and managed opioid reduction.

Highly commended - Patient safety (2019) - Bedfordshire CCG

The team presented their experience of a CCG wide audit on Atrial Fibrillation and anticoagulation and running Primary Care consultant led AF clinics.

In addition learning was shared on appropriate dosing of NOACs and a CCG wide approach to ensure the appropriate dosage; as well as changing to the lowest cost NOAC.

Highly commended - Big Idea (2018) - Luton CCG

The team from Luton CCG presented their highly commended 'Big Idea' on Improving Medicines Safety in Children with Complex Chronic Disease (CCD) across the interphases.

Hospital Admissions Related to Medicines (HARM) (2013)

Rita Sanghera, Medicines Optimisation Pharmacist from Arden CSU, presented the winning project in our 2013 Polypharmacy and Deprescribing Innovation Award category.

Medicines Safety Quality Improvement Projects (MSQIPs) (2023)

Safely stopping the prescribing of methotrexate 10mg tablets (2022)

Improving patient safety in Sefton (2022)

Highly commended - DOAC calculator (2023)

Improving safety and reducing prescribing of gabapentinoids in County Durham (2023)

Improving the safety of anaphylaxis care and adrenaline autoinjector prescribing in Surrey Heartlands (2022)

Oral Paracetamol dosing in low body weight patients (2022)

Penicillin Allergy De-labelling in Primary Care Pilot Project (2022)

Paracetamol Dosing In Low Weight Care Home Residents (2023)

Reducing the prescribing of weak opioids for chronic pain in County Durham (2023)

Improving anticoagulant dosing for atrial fibrillation in primary care (2022)

Kent and Medway System Wide Response to the Sodium Valproate Pregnancy Prevention Programme (2022)

Medication overuse headaches: a local picture and management strategies (2022)

Medicine Optimisation DOAC Safety Audit in all GP practices across Morecambe Bay CCG (2022)

Medicines management on Insulins (2022)

Highly commended - Reduction in the use of psychotropic medications with people who have learning disabilities (2021)

This is a regular virtual meeting bringing together subscribers with a shared interest in medicines safety, to discuss issues, challenges and experiences.

Find out more and sign up here

Register for our updates Register

Copyright© 2018 PrescQIPP. All rights reserved.

PrescQIPP C.I.C. is a community interest company limited by guarantee registered in England and Wales.
Registered office: Murray Harcourt, 6 Queen Street, Leeds, LS1 2TW
Company registration number: 9814012

Terms and conditions
Privacy policy